Streptococcus anginosus Group Bacterial Infections

Am J Med Sci. 2017 Sep;354(3):257-261. doi: 10.1016/j.amjms.2017.05.011. Epub 2017 May 24.

Abstract

Background: The Streptococcus anginosus group (SAG) causes a variety of infections in adults. To better understand the burden of SAG infections and their associated morbidity and mortality, we conducted a retrospective analysis of these infections in adults at a tertiary care center.

Methods: A retrospective review of all cultures positive for SAG in adults and a corresponding review of the patients' medical records were conducted at a tertiary care facility in central New York. Patients with these cultures during the period of January 2007-December 2011 were included. Demographic data, area of residence, clinical features and underlying illnesses, site of infection, length of hospital stay, antibiotic susceptibility and antibiotic therapy were recorded and analyzed.

Results: There were 332 SAG cases; most patients were males (59%), mean age of 47 years and 84% lived in urban areas. Overall mortality was 3% with underlying conditions common such as diabetes (25%), hypertension (31%) and immunodeficiency (22%). Most of the infections were related to skin and soft tissue (72%) and polymicrobial (70%) with gram-negative anaerobes and Enterobacteriaceae commonly isolated with SAG.

Conclusions: We present the largest study, thus far, reviewing the clinical presentation, management and outcome of infections due to the SAG of organisms. Notable findings from our study are the low mortality associated with SAG infection, and the propensity to present as a skin and tissue and polymicrobial infection. Our findings will assist clinicians in managing patients with SAG infections and recognizing that S anginosus may be one of several organisms responsible for infection.

Keywords: Burden; Mortality; Polymicrobial; Retrospective analysis; Streptococcus anginosus group.

MeSH terms

  • Adult
  • Anti-Bacterial Agents / administration & dosage
  • Anti-Bacterial Agents / therapeutic use
  • Debridement
  • Female
  • Humans
  • Length of Stay
  • Male
  • Microbial Sensitivity Tests
  • Middle Aged
  • New York / epidemiology
  • Retrospective Studies
  • Skin Diseases, Bacterial / microbiology*
  • Skin Diseases, Bacterial / mortality
  • Skin Diseases, Bacterial / therapy
  • Soft Tissue Infections / microbiology*
  • Soft Tissue Infections / mortality
  • Soft Tissue Infections / therapy
  • Streptococcal Infections / microbiology*
  • Streptococcal Infections / mortality
  • Streptococcal Infections / therapy
  • Streptococcus anginosus / isolation & purification*
  • Streptococcus anginosus / pathogenicity
  • Tertiary Care Centers

Substances

  • Anti-Bacterial Agents